MACKENZIE FINANCIAL CORP
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 919859
TORONTO ONTARIO, A6
Position in BMRN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$53,321,258
+$28,384,087 QoQ
Shares Held
931,864
+111.1% QoQ
Ownership
0.481%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#36
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACKENZIE FINANCIAL CORP holds $498,673,295 across 59 Biotechnology names. BMRN ranks #3 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
135,783 | $84,666,131 | |
| 2 | INCY |
Incyte Corp
|
634,862 | $71,967,956 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
931,864 | $53,321,258 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
102,928 | $51,127,425 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
298,440 | $22,227,811 | |
| 6 | TBPH |
Theravance Biopharma, Inc.
|
985,848 | $16,759,416 | |
| 7 | RPRX |
Royalty Pharma plc
|
270,457 | $15,164,523 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
43,988 | $13,241,707 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,321,258 | 931,864 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $24,937,171 | 441,444 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $22,290,231 | 375,067 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $9,490,294 | 175,227 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $6,709,803 | 122,063 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,825,652 | 68,265 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $14,504,047 | 220,661 | Shares | Sole | 2025-05-02 | |
| 2024-09-30 | $5,112,472 | 72,734 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,508,924 | 30,474 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,239,572 | 25,642 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $3,434,673 | 35,622 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $3,211,470 | 36,296 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $2,601,786 | 30,016 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $4,447,368 | 45,736 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $4,650,426 | 44,936 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,625,697 | 42,771 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $6,130,308 | 73,975 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $8,940,747 | 115,963 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,569,663 | 119,634 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,573,823 | 85,054 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $4,959,172 | 59,434 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $4,622,722 | 61,220 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $696,346 | 7,941 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $527,843 | 6,938 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $623,113 | 5,052 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $333,437 | 3,946 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||